News

Product Launch - AMP ELISA Tests SARS-CoV-2

Serological detection of antibodies to SARS-CoV-2 is a valuable supplement to RNA detection by RT-PCR, as it enables determination of the seroprevalence of a population, tracing of previous exposure and identification of highly reactive human donors for generation of convalescent plasma.

AMP ELISA Tests for detection of SARS-CoV-2 antibodies are utilising the characteristics of SARS-CoV-2 spike protein by applying recombinant SARS-CoV-2 antigens expressed in insect cells, including N-protein, S1-RBD and S2-ECD.

Three different kits are available for detection of IgM, IgG or total antibodies and all of them can be processed both with semi- or fully automated ELISA equipment.

AMP ELISA Test

SARS-CoV-2 IgG

AMP ELISA Test

SARS-CoV-2 IgM

AMP ELISA Test

SARS-CoV-2 Ab

Cat.No.

Kit content

Test principle

Sample material

Sample volume

Assay time

Sensitivity

Specificity

ER2241

96 tests

indirect EIA

serum, plasma

10 µL

70 minutes

95.90%

98.46%

ER2242

96 tests

capture EIA

serum, plasma

10 µL

70 minutes

100%

99.87%

ER2245

96 tests

double antigen sandwich EIA

serum, plasma

100 µL

70 minutes

100%

99.52%

Features and Benefits:

  • Proven and reliable EIA technology

  • Proteins N, S1-RBD and S2-ECD applied

  • No handling of viral genetic material- simple routine sample collection and preparation (serum/plasma)

  • Positive results also for low viral load samples

  • Short assay time (70 minutes)

  • Liquid ready-to-use reagents

  • Outstanding performance and reliability

Download Product Brochure (click PDF symbol)

  • Black Facebook Icon
  • Black LinkedIn Icon
  • Black Twitter Icon
  • Black Pinterest Icon